首页> 美国卫生研究院文献>Case Reports in Rheumatology >Successful Treatment of Sjögrens Syndrome Presenting as a Condition Similar to Chronic Capillary Leak Syndrome Using Combination Therapy with High-Dose Intravenous Immunoglobulin and Glucocorticoid
【2h】

Successful Treatment of Sjögrens Syndrome Presenting as a Condition Similar to Chronic Capillary Leak Syndrome Using Combination Therapy with High-Dose Intravenous Immunoglobulin and Glucocorticoid

机译:大剂量静脉注射免疫球蛋白和糖皮质激素联合治疗成功治疗干燥综合征(与慢性毛细血管渗漏综合征相似)

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A 70-year-old woman with Sjögren's syndrome (SS) complained of generalized edema. Computed tomography showed thoracoabdominal fluid, suggesting serositis with SS. 35 mg/day of prednisolone as a monotherapy was ineffective. Moreover, hemoconcentration with hypoalbuminemia without inflammatory signs lead us to consider the systemic capillary leak syndrome (SCLS). Additional treatment with intravenous immunoglobulin (IVIG) and prednisolone dramatically decreased the thoracoabdominal fluid. However, when reducing the prednisolone dose, the thoracoabdominal fluid reincreased. Retreatment with IVIG without increasing the prednisolone dose was ineffective. However, additional prednisolone of 35 mg/day was effective, suggesting SCLS with SS might require combination therapy with IVIG and glucocorticoid.
机译:一名患有Sjögren综合征(SS)的70岁女性抱怨全身水肿。计算机体层摄影术显示胸腹液,提示浆膜炎伴SS。泼尼松龙35 mg /天作为单一疗法无效。此外,血液浓缩并伴有低白蛋白血症而无炎症迹象,使我们考虑系统性毛细血管渗漏综合征(SCLS)。静脉注射免疫球蛋白(IVIG)和泼尼松龙的进一步治疗可大大减少胸腹水。但是,当降低泼尼松龙的剂量时,胸腹液会增加。在不增加泼尼松龙剂量的情况下用IVIG重新治疗无效。然而,额外的泼尼松龙35毫克/天是有效的,这表明SCLS与SS可能需要与IVIG和糖皮质激素联合治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号